Cargando…

Should parents be present during screening examinations for retinopathy of prematurity?

PURPOSE: To investigate whether parents should be present during screening examinations for retinopathy of prematurity (ROP) by investigating the anxiety levels of parents using two different approaches. METHODS: This cross-sectional and two-center study was carried out with the parents at the time...

Descripción completa

Detalles Bibliográficos
Autores principales: Kara, Caner, Özdemir, Özdemir, Petriçli, Ikbal S, Acar, Damla E, Tunay, Zuhal Ö
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482911/
https://www.ncbi.nlm.nih.gov/pubmed/34304194
http://dx.doi.org/10.4103/ijo.IJO_2707_20
_version_ 1784577007072313344
author Kara, Caner
Özdemir, Özdemir
Petriçli, Ikbal S
Acar, Damla E
Tunay, Zuhal Ö
author_facet Kara, Caner
Özdemir, Özdemir
Petriçli, Ikbal S
Acar, Damla E
Tunay, Zuhal Ö
author_sort Kara, Caner
collection PubMed
description PURPOSE: To investigate whether parents should be present during screening examinations for retinopathy of prematurity (ROP) by investigating the anxiety levels of parents using two different approaches. METHODS: This cross-sectional and two-center study was carried out with the parents at the time of the first ROP screening examination of their premature infants. At one center, the parents accompanied the infants during the ROP examination (Group 1), and in the other center, they did not (Group 2). Anxiety levels were assessed with the State-Trait Anxiety Inventory (STAI), which consists of the State Anxiety (STAI-S) and Trait Anxiety (STAI-T) subscales and a visual analog scale (VAS). RESULTS: A total of 147 parents of 127 infants were included in the study. STAI-T and -S levels were 40.5 ± 8 and 37.9 ± 7.5, respectively, in Group 1 and 39.6 ± 8.1 and 39.4 ± 9.1 in Group 2 before the examination. There were no statistically significant differences in terms of these values between the two groups (P > 0.05). The state anxiety levels increased by an average of 1.7 ± 8 in Group 1 and reached 39.6 ± 10.1 after the examination. In Group 2, these levels decreased by an average of − 2.7 ± 7.5 points to a score of 36.4 ± 10.3. This difference was found to be statistically significant (P = 0.001). A similar pattern was observed in the evaluation of the VAS data. CONCLUSION: As a preliminary opinion, it may be more appropriate for parents to not participate in screening examinations, but single-center controlled studies are required to confirm the results.
format Online
Article
Text
id pubmed-8482911
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-84829112021-10-14 Should parents be present during screening examinations for retinopathy of prematurity? Kara, Caner Özdemir, Özdemir Petriçli, Ikbal S Acar, Damla E Tunay, Zuhal Ö Indian J Ophthalmol Special Focus on Retinopathy of Prematurity, Original Article PURPOSE: To investigate whether parents should be present during screening examinations for retinopathy of prematurity (ROP) by investigating the anxiety levels of parents using two different approaches. METHODS: This cross-sectional and two-center study was carried out with the parents at the time of the first ROP screening examination of their premature infants. At one center, the parents accompanied the infants during the ROP examination (Group 1), and in the other center, they did not (Group 2). Anxiety levels were assessed with the State-Trait Anxiety Inventory (STAI), which consists of the State Anxiety (STAI-S) and Trait Anxiety (STAI-T) subscales and a visual analog scale (VAS). RESULTS: A total of 147 parents of 127 infants were included in the study. STAI-T and -S levels were 40.5 ± 8 and 37.9 ± 7.5, respectively, in Group 1 and 39.6 ± 8.1 and 39.4 ± 9.1 in Group 2 before the examination. There were no statistically significant differences in terms of these values between the two groups (P > 0.05). The state anxiety levels increased by an average of 1.7 ± 8 in Group 1 and reached 39.6 ± 10.1 after the examination. In Group 2, these levels decreased by an average of − 2.7 ± 7.5 points to a score of 36.4 ± 10.3. This difference was found to be statistically significant (P = 0.001). A similar pattern was observed in the evaluation of the VAS data. CONCLUSION: As a preliminary opinion, it may be more appropriate for parents to not participate in screening examinations, but single-center controlled studies are required to confirm the results. Wolters Kluwer - Medknow 2021-08 2021-07-26 /pmc/articles/PMC8482911/ /pubmed/34304194 http://dx.doi.org/10.4103/ijo.IJO_2707_20 Text en Copyright: © 2021 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Special Focus on Retinopathy of Prematurity, Original Article
Kara, Caner
Özdemir, Özdemir
Petriçli, Ikbal S
Acar, Damla E
Tunay, Zuhal Ö
Should parents be present during screening examinations for retinopathy of prematurity?
title Should parents be present during screening examinations for retinopathy of prematurity?
title_full Should parents be present during screening examinations for retinopathy of prematurity?
title_fullStr Should parents be present during screening examinations for retinopathy of prematurity?
title_full_unstemmed Should parents be present during screening examinations for retinopathy of prematurity?
title_short Should parents be present during screening examinations for retinopathy of prematurity?
title_sort should parents be present during screening examinations for retinopathy of prematurity?
topic Special Focus on Retinopathy of Prematurity, Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482911/
https://www.ncbi.nlm.nih.gov/pubmed/34304194
http://dx.doi.org/10.4103/ijo.IJO_2707_20
work_keys_str_mv AT karacaner shouldparentsbepresentduringscreeningexaminationsforretinopathyofprematurity
AT ozdemirozdemir shouldparentsbepresentduringscreeningexaminationsforretinopathyofprematurity
AT petricliikbals shouldparentsbepresentduringscreeningexaminationsforretinopathyofprematurity
AT acardamlae shouldparentsbepresentduringscreeningexaminationsforretinopathyofprematurity
AT tunayzuhalo shouldparentsbepresentduringscreeningexaminationsforretinopathyofprematurity